Poolbeg Pharma receives US Patent Office Allowance for Immunomodulator II
Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application. This AIM-traded firm said the development